Windlas Biotech Ltd reports Q2 revenue of ₹263.91 crore and net profit of ₹18.05 crore
- Revenue rose 18.7% year on year and 6.4% sequentially; net profit increased 1.4% and 2.3%, respectively. EBITDA margin was 11.1%.
- Board accepted Ashok Kumar Windlass’s resignation as Whole-time Director and Director, effective November 5; he will become Founder President/Senior Management Personnel from November 6, subject to shareholder approval.
- Managing Director Hitesh Windlass was appointed Chairman, effective November 5. The limited-review conclusion was unmodified; the auditor noted the dissolution of the US subsidiary.